Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis

BACKGROUND: PDZ-binding kinase/T-lymphokine-activated killer cell-derived protein kinase (PBK/TOPK) is a potential prognostic indicator for patients with breast cancer. The objective of the present study was to explore the relationship between PBK/TOPK expression and clinicopathological indicators a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Liang, Ba, Jinling, Xie, Jiping, Zhu, Ruiping, Wan, Yi, Zhang, Min, Jin, Zeyu, Guo, Zicheng, Yu, Jiaxuan, Chen, Sijing, Yao, Yongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520922/
https://www.ncbi.nlm.nih.gov/pubmed/36171591
http://dx.doi.org/10.1186/s12957-022-02769-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520922/
https://www.ncbi.nlm.nih.gov/pubmed/36171591
http://dx.doi.org/10.1186/s12957-022-02769-x

Ejemplares similares